12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
restriction
1/25/2009 Link
to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS
ONE
Carmen L. Underwood, Ph.D. Director
Dr. Carmen L. Underwood is the Chief Operating Officer at APT Pharmaceuticals, a drug manufacturer focused on repurposing well-characterized medicines for under-served populations. Carmen used to serve as the Head of West Coast Operations for Thrive, a product development and innovation strategy firm. He also spent 9 years in biological research and development for AstraZeneca, a research-based biopharmaceutical company. Carmen has been involved with the development and approval of several medications in America and Europe. He earned a Ph.D in immunology from Georgia State University and earned a fellowship from the Georgia Health Sciences University.